World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
16317
World Ranking
2429
National Ranking
168

Gerd Sutter publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gerd Sutter sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 216 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gerd Sutter D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gerd Sutter sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gerd Sutter is affiliated with Ludwig-Maximilians-Universität München in Germany and has contributed extensively to the field of medicine, focusing mainly on infectious diseases. Their research covers a broad scope within immunology, epidemiology, animal science and zoology, and genetics.

The scientist's work is frequently published in several notable journals. The venues with the highest number of publications include Vaccines, bioRxiv (Cold Spring Harbor Laboratory), Viruses, Frontiers in Immunology, and Nature Communications.

Sutter's main research fields encompass:

  • Medicine

Within these, the key subfields of study are:

  • Infectious Diseases
  • Immunology
  • Epidemiology
  • Animal Science and Zoology
  • Genetics

The primary topics addressed in Sutter's work include:

  • SARS-CoV-2 and COVID-19 Research
  • Animal Virus Infections Studies
  • Virus-based gene therapy research
  • Viral Infections and Outbreaks Research
  • Viral Infections and Vectors
  • Immunotherapy and Immune Responses
  • Viral gastroenteritis research and epidemiology

Frequently collaborating coauthors include:

  • Asisa Volz
  • Alina Tscherne
  • Stephan Becker
  • Georgia Kalodimou
  • Christine Dahlke

Representative recent papers by Gerd Sutter include:

  • Diverse variola virus (smallpox) strains were widespread in northern Europe in the Viking Age, 2020, Science
  • Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial, 2020, The Lancet Infectious Diseases
  • Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination, 2021, Proceedings of the National Academy of Sciences
  • Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise, 2020, Vaccines
  • Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents, 2021, Frontiers in Immunology

Best Publications

  • A Toll-like receptor–independent antiviral response induced by double-stranded B-form DNA

    Ken J Ishii;Cevayir Coban;Hiroki Kato;Ken Takahashi

  • Nonreplicating vaccinia vector efficiently expresses recombinant genes

    Gerd Sutter;Bernard Moss

  • Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.

    H. Meyer;G. Sutter;A. Mayr

  • IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice

    Vincenzo Bronte;Paolo Serafini;Carmela De Santo;Ilaria Marigo

  • Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.

    V M Hirsch;T R Fuerst;G Sutter;M W Carroll

  • A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

    Gerd Sutter;Linda S. Wyatt;Patricia L. Foley;Jack R. Bennink

  • Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells.

    Ingo Drexler;Karl Heller;Britta Wahren;Volker Erfle

  • Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development

    A. Volz;Gerd Sutter

  • Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells.

    Stephan Halle;Hélène C. Dujardin;Nadja Bakocevic;Henrike Fleige

  • An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

    Bart L. Haagmans;Judith M. A. van den Brand;V. Stalin Raj;Asisa Volz

  • Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239

    Helen Horton;Thorsten U. Vogel;Donald K. Carter;Kathy Vielhuber

  • Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase

    Gerd Sutter;Marion Ohlmann;Volker Erfle

  • In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity

    Stephan Halle;Kirsten Anja Keyser;Felix Rolf Stahl;Andreas Busche

  • Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery.

    Gerd Sutter;Caroline Staib

  • Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

    Asisa Volz;Alexandra Kupke;Fei Song;Sylvia Jany

  • Modified vaccinia virus Ankara as antigen delivery system: how can we best use its potential?

    Ingo Drexler;Caroline Staib;Gerd Sutter

  • IL-17–induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs

    Henrike Fleige;Sarina Ravens;Georgios Leandros Moschovakis;Jasmin Bölter

  • Functional Role of Human Leukocyte Antigen-G Up-Regulation in Renal Cell Carcinoma

    Jürgen Bukur;Vera Rebmann;Hans Grosse-Wilde;Hans Luboldt

  • Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.

    Till Koch;Till Koch;Christine Dahlke;Christine Dahlke;Anahita Fathi;Anahita Fathi;Alexandra Kupke

  • Middle east respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus ankara efficiently induces virus-neutralizing antibodies

    Fei Song;Robert Fux;Lisette B. Provacia;Asisa Volz

  • Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

    Ingo Drexler;Caroline Staib;Wolfgang Kastenmüller;Stefan Stevanović

Frequent Co-Authors

Volker Erfle
Volker Erfle Technical University of Munich
Albert D. M. E. Osterhaus
Albert D. M. E. Osterhaus University of Veterinary Medicine Hannover, Foundation
Ulrich Kalinke
Ulrich Kalinke Hannover Medical School
Guus F. Rimmelzwaan
Guus F. Rimmelzwaan University of Veterinary Medicine Hannover, Foundation
Ron A. M. Fouchier
Ron A. M. Fouchier Erasmus University Rotterdam
Bernard Moss
Bernard Moss National Institutes of Health
Jonathan L. Heeney
Jonathan L. Heeney University of Cambridge
Peter Liljeström
Peter Liljeström Karolinska Institute
Reinhold Förster
Reinhold Förster Hannover Medical School
Thijs Kuiken
Thijs Kuiken Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Many professionals consider advancing their skills through specialized nursing programs. For example, the cheapest online pmhnp programs offer an affordable route to become a Psychiatric Mental Health Nurse Practitioner, combining immunology knowledge with mental health care.

Understanding potential earnings is crucial when choosing a nursing degree. The average salary for a Doctor of Nursing Practice varies by state, and it’s helpful to research how much does a dnp make to make informed career decisions. Competitive salaries reflect the high demand for advanced nursing roles.

Nurses seeking to expand their clinical expertise can also explore bridge programs. Transitioning from a Family Nurse Practitioner to an acute care specialist is streamlined through an fnp to acnp bridge program online, which prepares them for critical roles in acute care settings.

For those looking for a fast track, enrolling in an accelerated np program can expedite the path to becoming a Nurse Practitioner. These programs are designed to efficiently prepare students for advanced practice, often accommodating working professionals.

Best Scientists Citing Gerd Sutter

Trending Scientists

Recently Published Articles